# Endocannabinoid System: Cannabis Anxiety Research 2026 > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/endocannabinoid-system-cannabis-anxiety-research/ > **Published:** 2026-04-01T10:02:34-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T11:57:06-04:00 > **Clinical Summary:** Explore endocannabinoid system cannabis anxiety research revealing how CBD and THC products impact anxiety relief differently in 2026 studies. --- #### Clinical Takeaway Cannabis use for anxiety produces measurable daily reductions in anxiety symptoms, but the magnitude and pattern of relief differ depending on whether flower or edible products are used. CBD-containing products showed anxiolytic effects, while the role of THC varied by product format and cannabinoid ratio. Patients considering cannabis for [anxiety management](https://cedclinic.com/cannabis-and-ptsd-treatment-memory-loss-benefits/) should understand that product type and delivery method meaningfully influence both immediate and longer-term outcomes. ### #9 Therapeutically Motivated Cannabis Use for Anxiety: Daily and Longitudinal Reductions Vary Between Flower and Edible Products. **Citation:** Rosa Luiza et al. *Therapeutically Motivated Cannabis Use for Anxiety: Daily and Longitudinal Reductions Vary Between Flower and Edible Products.* International journal of environmental research and public health. 2026. PMID: 41752306. **Study type:** Journal Article, Randomized Controlled Trial  |  **Topic area:** Cannabidiol  |  **CED Score:** 11 Design: 5 Journal: 0 N: 2 Recency: 3 Pop: 2 Human: 1 Risk: -2 **Quality Gate Alerts:** - Preclinical only **Abstract:** Research shows that delta-9-tetrahydrocannabinol (THC) is linked to increased anxiety, while cannabidiol (CBD) may have anxiolytic effects. Cannabis use is often driven by coping with anxiety, though its daily impact on anxiety remains unclear. This study examined daily associations between cannabis use and anxiety across 30 days in adults who wanted to use cannabis for [anxiety relief](https://cedclinic.com/cannabis-based-medicine-ptsd-anxiety-relief/). Participants (N = 345) used flower or edible products ad libitum and were randomly assigned to groups by product type (CBD, THC, or THC + CBD). Each day, participants reported cannabis use in the past 24 h and rated their anxiety. Linear mixed-effects models tested whether anxiety changed over time, differed by cannabinoid group, and varied with use. Anxiety significantly decreased over the study period in both flower and edibles groups. In the flower group, THC + CBD and [CBD products](https://cedclinic.com/fda-warning-on-cbd-products/) had greater decreases in anxiety (39.5% and 34.8%, respectively) compared to THC products (7.8%). In the edibles group, when participants used CBD products, this was associated with a 24.9% reduction in anxiety over the 30 days. Findings underscore the importance of distinguishing cannabis effects by product type and cannabinoid composition and suggest that CBD-dominant edibles were associated with less anxiety over time in this naturalistic study.  |   |  [View on PubMed ↗](https://pubmed.ncbi.nlm.nih.gov/41752306/)[Full Text ↗](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12941097/)[DOI ↗](https://doi.org/10.3390/ijerph23020224) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Endocannabinoid System Cannabis Anxiety Treatment Evidence](https://cedclinic.com/cbd-dominant-cannabis-anxiety-relief-study/) Review clinical evidence on how the [endocannabinoid system](https://cedclinic.com/endocannabinoid-system-fear-extinction/) mediates cannabis treatment effects for anxiety. [Read More](https://cedclinic.com/cbd-dominant-cannabis-anxiety-relief-study/) [Endocannabinoid System Research: Cannabis Anxiety Treatment](https://cedclinic.com/cbd-dominant-cannabis-anxiety-relief-study/) Explore research findings on cannabis use targeting the endocannabinoid system for anxiety relief. [Explore Research](https://cedclinic.com/cbd-dominant-cannabis-anxiety-relief-study/) [Endocannabinoid System & Cannabis Anxiety Treatment](https://cedclinic.com/daily-cannabis-anxiety-relief-outcomes/) Understand the role of the endocannabinoid system in cannabis-based [anxiety treatment](https://cedclinic.com/benzodiazepine-discontinuation-rates-medical-cannabis/) strategies. [Learn More](https://cedclinic.com/daily-cannabis-anxiety-relief-outcomes/) Have thoughts on this? Share it: [X Share on X](https://twitter.com/intent/tweet?text=Endocannabinoid%20System%3A%20Cannabis%20Anxiety%20Research%202026&url=https%3A%2F%2Fcedclinic.com%2Fendocannabinoid-system-cannabis-anxiety-research%2F) [in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fcedclinic.com%2Fendocannabinoid-system-cannabis-anxiety-research%2F) [Share on BlueSky](https://bsky.app/intent/compose?text=Endocannabinoid%20System%3A%20Cannabis%20Anxiety%20Research%202026%20https%3A%2F%2Fcedclinic.com%2Fendocannabinoid-system-cannabis-anxiety-research%2F) [Follow on Instagram](https://www.instagram.com/drbenjamincaplan) [Read more on Substack](https://doctorapprovedcannabis.substack.com/) [Subscribe via RSS](https://cedclinic.com/feed/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).